Status:
COMPLETED
A Randomized Study of Cervical Priming With Misoprostol Prior to Elective First Trimester Pregnancy Termination
Lead Sponsor:
Kaiser Permanente
Conditions:
Abortion, Therapeutic
Eligibility:
FEMALE
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine whether misoprostol administered prior to elective first trimester pregnancy has an effect on pain and ease of procedure and complications.
Detailed Description
Previous studies suggest that cervical priming with misoprostol may facilitate vacuum aspiration for first trimester termination by inducing cervical dilation. This medication is used routinely at som...
Eligibility Criteria
Inclusion
- Subjects must meet the following inclusion criteria: after completion of a full history and physical exam each subject must be judged physically and mentally stable by the enrolling practitioner; subjects must be between 7 and 11 weeks pregnant and desiring termination. Gestation dating must be based on a reliable menstrual history consistent with a bimanual exam or ultrasound. All subjects must give informed consent after the study has been explained.
Exclusion
- Subject must not have a physical or mental health condition which could be adversely affected by the study drug, including a history of allergy to prostaglandins or, specifically, to misoprostol.
Key Trial Info
Start Date :
May 1 2001
Trial Type :
INTERVENTIONAL
End Date :
May 1 2006
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00310921
Start Date
May 1 2001
End Date
May 1 2006
Last Update
April 11 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente, Department of OB/GYN
San Francisco, California, United States, 94115